Journals / Viral Hepatitis Journal / 2019 / Cilt: 25 - Sayı: 2

Viral Hepatitis Prevalence in Two Cognitively Different Risk Groups

Bilişsel Olarak Farklı İki Risk Grubunda Viral Hepatit Sıklığı

Pages
78–83
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Anti-HBs positivity was found significantly lower in the SCRCMD group compared to the HCW group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aimed to investigate whether patient awareness of viral hepatitis affected the prevalence of the condition by comparing the awareness levels in two high-risk groups with different cognitive abilities.Materials and Methods: Hepatitis B surface antigen (HBsAg), anti-HBs, anti-HAV immunoglobulin G (IgG), anti-HCV and Human Immunodeficiency Virus (HIV) seropositivity values of healthcare workers (HCWs) working in a state hospital and of individuals treated in a State Care and Rehabilitation Center for the Mentally Disabled (SCRCMD) between January 1, 2016 and December 31, 2018 were analyzed retrospectively.Results: One hundred and two HCWs and 110 individuals followed-up by the SCRCMD were included in the study.
📊
Key Findings & Data:Of the HCWs, two (2%) were HBsAg positive, 93 (91.2%) were anti-HBs positive and 85 (83.3%) were anti-HAV IgG positive.
💡
Conclusion & Impact:Anti-HBs positivity was found significantly lower in the SCRCMD group compared to the HCW group (p
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aimed to investigate whether patient awareness of viral hepatitis affected the prevalence of the condition by comparing the awareness levels in two high-risk groups with different cognitive abilities.Materials and Methods: Hepatitis B surface antigen (HBsAg), anti-HBs, anti-HAV immunoglobulin G (IgG), anti-HCV and Human Immunodeficiency Virus (HIV) seropositivity values of healthcare workers (HCWs) working in a state hospital and of individuals treated in a State Care and Rehabilitation Center for the Mentally Disabled (SCRCMD) between January 1, 2016 and December 31, 2018 were analyzed retrospectively.Results: One hundred and two HCWs and 110 individuals followed-up by the SCRCMD were included in the study. Of the HCWs, two (2%) were HBsAg positive, 93 (91.2%) were anti-HBs positive and 85 (83.3%) were anti-HAV IgG positive. None of the HCWs were anti-HCV or HIV positive. Of the individuals followed-up by the SCRCMD, eight (7.3%) were HBsAg positive, 61 (55.5%) were anti-HBs positive, 95 (86.4%) were anti-HAV IgG positive and one (0.9%) was anti-HCV positive. None of the individuals followed-up by the SCRCMD were HIV positive. Anti-HBs positivity was found significantly lower in the SCRCMD group compared to the HCW group (p

Özet

Amaç: Bu çalışma ile viral hepatitler için yüksek risk grubunda olan fakat bilişsel olarak farklı iki grup arasındaki hastalık farkındalığının hastalık sıklığını etkileyip etkilemediğinin araştırılması amaçlandı. Gereç ve Yöntemler: Kamuya bağlı devlet hastanesi sağlık çalışanları ile yine kamuya bağlı Ruhsal Engelli Bakım ve Rehabilitasyon Merkezi’nde (REBRM) yaşayan bireylerin 1 Ocak 2016 - 31 Aralık 2018 tarihleri arasındaki hepatit B yüzey antijeni (HBsAg), anti-HBs, anti-HAV immünoglobulin G (IgG), anti-HCV, HIV seropozitiflik durumları retrospektif olarak incelendi. Bulgular: Çalışmaya 102 sağlık çalışanı ve REBRM’de takip edilen 110 birey dahil edildi. Sağlık çalışanlarının ikisinde (%2) HBsAg pozitif, 93’ünde (%91,2) anti-HBs pozitif ve 85’inde (%83,3) anti-HAV IgG pozitifliği saptanırken, hiçbir sağlık çalışanında anti-HCV ve HIV pozitifliği saptanmadı. REBRM’de takip edilen bireylerin 8’inde (%7,3) HBsAg pozitif, 61’inde (%55,5) anti-HBs pozitif, 95’inde (%86,4) anti-HAV IgG pozitif ve birinde (%0,9) ise anti-HCV pozitifliği saptandı. REBRM bireylerin hiçbirinde HIV pozitifliği saptanmadı. Sağlık çalışanlarına göre REBRM’deki bireylerde anti-HBs pozitifliği anlamlı olarak düşük saptandı (p

🔖

Cite This Article

KARADABAN, K., KARLIDAĞ, G. E. (2022). Viral Hepatitis Prevalence in Two Cognitively Different Risk Groups. Viral Hepatitis Journal, Cilt: 25 - Sayı: 2, 78–83. https://ajindex.com/articles/646373

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, Assadi R, Bhala N, Cowie B, Forouzanfour MH, Groeger J, Hanafiah KM, Jacobsen KH, James SL, MacLachlan J, Malekzadeh R, Martin NK, Mokdad AA, Mokdad AH, Murray CJL, Plass D, Rana S, Rein DB, Richardus JH, Sanabria J, Saylan M, Shahraz S, So S, Vlassov VV, Weiderpass E, Wiersma ST, Younis M, Yu C, El Sayed Zaki M, Cooke GS. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016
  2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013
  3. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci. 2005
  4. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O. Seroprevalance of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015
  5. Prüss-Ustün A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med. 2005
  6. Kakisi OK, Grammatikos AA, Karageorgopoulos DE, Athanasoulia AP, Papadopoulou AV, Falagas ME. Prevalence of hepatitis B, hepatitis C, and HIV infections among patients in a psychiatric hospital in Greece. Psychiatr Serv. 2009
  7. European Association for the Study of the Liver. Electronic address: [email protected]
  8. European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017
  9. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 1997
  10. Keçik Boşnak V, Karaoğlan İ, Namıduru M, Şahin A. Seroprevalences of Hepatitis B, Hepatitis C, HIV of the Healthcare Workers in the Gaziantep University Sahinbey Research and Training Hospital. Viral Hepatitis Journal. 2013
  11. European Centre for Disease Prevention and Control. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Stockholm: ECDC
  12. Available from: http://www.ecdc.europa.eu/en/publications/Publication